会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • REAGENTS FOR THE DETECTION OF PROTEIN ACETYLATION SIGNALING PATHWAYS
    • 检测蛋白质乙酰化信号途径的试剂
    • WO2007133689A3
    • 2008-06-26
    • PCT/US2007011420
    • 2007-05-11
    • CELL SIGNALING TECHNOLOGY INCGUO AILANLI YUGU TING-LEIMITCHELL JEFFREYHORNBECK PETER
    • GUO AILANLI YUGU TING-LEIMITCHELL JEFFREYHORNBECK PETER
    • G01N33/53
    • G01N33/6842C07K16/44
    • The invention discloses 426 novel acetylation sites identified in signal transduction proteins and pathways underlying human protein acetylation signaling pathways, and provides acetylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these acetylated sites/proteins, as well as methods of using the reagents for such purpose. Among the acetylation sites identified are sites occurring in the following protein types: Methyltransferases, Transcription factors, Transcription coactivators, Translation initiation complex proteins, Oxireductases, Protein kinases, RNA binding proteins, Secreted proteins, Transferases, Transporter proteins, Ubiquitin conjugating system proteins, Motor proteins, Phosphotases, Proteases, Phospholipases, Receptor proteins and Vesicle proteins.
    • 本发明公开了在信号转导蛋白中鉴定的426个新的乙酰化位点和人蛋白质乙酰化信号通路的途径,并提供乙酰化位点特异性抗体和重同位素标记肽(AQUA肽),用于选择性检测和定量这些乙酰化位点/蛋白质 ,以及使用试剂用于此目的的方法。 确定的乙酰化位点之间的位点是发生在以下蛋白质类型中的位点:甲基转移酶,转录因子,转录共激活子,翻译起始复合蛋白​​,氧化还原酶,蛋白激酶,RNA结合蛋白,分泌蛋白,转移酶,转运蛋白,泛素缀合系统蛋白,马达 蛋白质,磷酸酶,蛋白酶,磷脂酶,受体蛋白和囊泡蛋白。
    • 6. 发明申请
    • REAGENTS FOR THE DETECTION OF PROTEIN PHOSPHORYLATION IN SIGNALING PATHWAYS
    • 用于检测信号通路中的蛋白质磷酸化的试剂
    • WO2008008998A2
    • 2008-01-17
    • PCT/US2007/073534
    • 2007-07-13
    • CELL SIGNALING TECHNOLOGY, INC.HORNBECK, PeterGOSS, ValerieLEE, KimberlyGU, Ting-LeiMORITZ, Albrecht
    • HORNBECK, PeterGOSS, ValerieLEE, KimberlyGU, Ting-LeiMORITZ, Albrecht
    • G01N33/53
    • G01N33/68C07K16/18C07K16/32C07K16/40G01N33/60G01N33/6842G01N33/6845G01N33/6848
    • The invention discloses novel phosphorylation sites identified in signal transduction proteins and pathways, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: adaptor/scaffold proteins, adhesion/extracellular matrix protein, apoptosis proteins, calcium binding proteins, cell cycle regulation proteins, chaperone proteins, chromatin, DNA binding/repair/replication proteins, cytoskeletal proteins, endoplasmic reticulum or golgi proteins, enzyme proteins, G/regulator proteins, inhibitor proteins, motor/contractile proteins, phosphatase, protease, Ser/ Thr protein kinases, protein kinase (Tyr)s, receptor/channel/cell suface proteins, RNA binding proteins, transcriptional regulators, tumor suppressor proteins, ubiquitan conjugating system proteins and proteins of unknown function.
    • 本发明公开了在信号转导蛋白质和途径中鉴定的新的磷酸化位点,并提供磷酸化位点特异性抗体和重同位素标记肽(AQUA肽)用于选择性检测和定量这些磷酸化位点/ 蛋白质以及为此目的使用试剂的方法。 在所鉴定的磷酸化位点中存在发生在以下蛋白质类型中的位点:衔接子/支架蛋白质,粘附/细胞外基质蛋白质,凋亡蛋白质,钙结合蛋白质,细胞周期调节蛋白质,分子伴侣蛋白质,染色质,DNA结合/修复/ 细胞骨架蛋白,内质网或高尔基蛋白,酶蛋白,G /调节蛋白,抑制蛋白,运动/收缩蛋白,磷酸酶,蛋白酶,Ser / Thr蛋白激酶,蛋白激酶(Tyr) RNA结合蛋白,转录调节因子,肿瘤抑制蛋白,泛素缀合系统蛋白和功能未知的蛋白。
    • 7. 发明申请
    • REAGENTS FOR THE DETECTION OF PROTEIN ACETYLATION SIGNALING PATHWAYS
    • 检测蛋白质乙酰化信号途径的试剂
    • WO2007133689A2
    • 2007-11-22
    • PCT/US2007/011420
    • 2007-05-11
    • CELL SIGNALING TECHNOLOGY, INC.GUO, AilanLI, YuGU, Ting-leiMITCHELL, JeffreyHORNBECK, Peter
    • GUO, AilanLI, YuGU, Ting-leiMITCHELL, JeffreyHORNBECK, Peter
    • B21D11/10
    • G01N33/6842C07K16/44
    • The invention discloses 426 novel acetylation sites identified in signal transduction proteins and pathways underlying human protein acetylation signaling pathways, and provides acetylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these acetylated sites/proteins, as well as methods of using the reagents for such purpose. Among the acetylation sites identified are sites occurring in the following protein types: Methyltransferases, Transcription factors, Transcription coactivators, Translation initiation complex proteins, Oxireductases, Protein kinases, RNA binding proteins, Secreted proteins, Transferases, Transporter proteins, Ubiquitin conjugating system proteins, Motor proteins, Phosphotases, Proteases, Phospholipases, Receptor proteins and Vesicle proteins.
    • 本发明公开了在信号转导蛋白中鉴定的426个新的乙酰化位点和人蛋白质乙酰化信号通路的途径,并提供乙酰化位点特异性抗体和重同位素标记肽(AQUA肽),用于选择性检测和定量这些乙酰化位点/蛋白质 ,以及使用试剂用于此目的的方法。 确定的乙酰化位点之间的位点是发生在以下蛋白质类型中的位点:甲基转移酶,转录因子,转录共激活因子,翻译起始复合蛋白​​,氧化还原酶,蛋白激酶,RNA结合蛋白,分泌蛋白,转移酶,转运蛋白,泛素缀合系统蛋白,马达 蛋白质,磷酸酶,蛋白酶,磷脂酶,受体蛋白和囊泡蛋白。
    • 8. 发明申请
    • REAGENTS FOR THE DETECTION OF PROTEIN PHOSPHORYLATION IN LEUKEMIA SIGNALING PATHWAYS
    • 用于检测白血病信号途径中蛋白质磷酸化的试剂
    • WO2007064743A2
    • 2007-06-07
    • PCT/US2006/045760
    • 2006-11-29
    • CELL SIGNALING TECHNOLOGY, INC.POLAKIEWICZ, RobertoLEE, KimberlyGU, Ting-leiGOSS, Valerie
    • POLAKIEWICZ, RobertoLEE, KimberlyGU, Ting-leiGOSS, Valerie
    • G01N33/574
    • G01N33/57426
    • The invention discloses nearly 123 novel phosphorylation sites identified in signal transduction proteins and pathways underlying human Leukemia, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: protein kinases, adaptor/scaffold proteins, phosphatase/phospholipases, G proteins/GTPase activating proteins/guanine nucleotide exchange factors, cellular metabolism enzymes, DNA binding proteins, cytoskeletal proteins, cell cycle regulation proteins, proteases, RNA binding proteins, transcription proteins, translation initiation complex proteins, transferases, ubiquitin conjugating system proteins, vesicle proteins, actin binding proteins, apoptosis proteins, chemokine proteins, enzyme proteins extra cellular matrix proteins, helicases, hydrolases, immunoglobin superfamily proteins, inhibitor proteins, isomerases, ligases, lipid binding proteins, methyltransferases, motor proteins, receptor proteins, and chaperone proteins.
    • 本发明公开了在信号转导蛋白中识别的近123个新的磷酸化位点和人类白血病的途径,并提供磷酸化位点特异性抗体和重同位素标记肽(AQUA肽),用于选择性检测和定量这些磷酸化位点/蛋白,如 以及使用试剂用于此目的的方法。 鉴定的磷酸化位点是发生在以下蛋白质类型中的位点:蛋白激酶,衔接子/支架蛋白,磷酸酶/磷脂酶,G蛋白/ GTPase激活蛋白/鸟嘌呤核苷酸交换因子,细胞代谢酶,DNA结合蛋白,细胞骨架蛋白,细胞 循环调节蛋白,蛋白酶,RNA结合蛋白,转录蛋白,翻译起始复合蛋白​​,转移酶,泛素缀合系统蛋白,囊泡蛋白,肌动蛋白结合蛋白,凋亡蛋白,趋化因子蛋白,酶蛋白超细胞基质蛋白,解旋酶,水解酶,免疫球蛋白 超家族蛋白,抑制蛋白,异构酶,连接酶,脂质结合蛋白,甲基转移酶,运动蛋白,受体蛋白和伴侣蛋白。
    • 9. 发明申请
    • REAGENTS FOR THE DETECTION OF PROTEIN PHOSPHORYLATION IN LEUKEMIA SIGNALING PATHWAYS
    • 用于检测白血病信号途径中蛋白质磷酸化的试剂
    • WO2007027957A2
    • 2007-03-08
    • PCT/US2006/034126
    • 2006-08-30
    • CELL SIGNALING TECHNOLOGY, INC.POLAKIEWICZ, RobertoGOSS, ValerieLEE, KimberlyGU, Ting-leiMORITZ, Albrecht
    • POLAKIEWICZ, RobertoGOSS, ValerieLEE, KimberlyGU, Ting-leiMORITZ, Albrecht
    • G01N33/574
    • G01N33/57426C07B59/008C07K16/3061C07K16/44G01N33/6803G01N33/6842G01N2333/9121
    • The invention discloses nearly 480 novel phosphorylation sites identified in signal transduction proteins and pathways underlying human Leukemia, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: adaptor/scaffold proteins, acetyltransferases, actin binding proteins, adhesion proteins, apoptosis proteins, calcium-binding proteins, cell cycle regulation proteins, cell surface proteins, channel proteins, chaperone proteins, contractile proteins, cytokine proteins, cytoskeletal proteins, G protein regulators and GTPase activating proteins, guanine nucleotide exchange factors, helicase proteins, immunoglobulin superfamily proteins, inhibitor proteins, protein kinases, lipid kinases, ligases, lipid binding proteins, methytransferases, motor proteins, oxidoreductases, phosphotases, phosphodiesterases, phospholipases, proteases, receptor proteins, trascription factors, transferases, translation/transporter proteins, and ubiquitin conjugating system proteins.
    • 本发明公开了在信号转导蛋白中识别的近480个新的磷酸化位点和人类白血病的途径,并提供磷酸化位点特异性抗体和重同位素标记肽(AQUA肽),用于选择性检测和定量这些磷酸化位点/蛋白质,如 以及使用试剂用于此目的的方法。 鉴定的磷酸化位点是发生在以下蛋白质类型中的位点:衔接子/支架蛋白,乙酰转移酶,肌动蛋白结合蛋白,粘附蛋白,凋亡蛋白,钙结合蛋白,细胞周期调节蛋白,细胞表面蛋白,通道蛋白,伴侣蛋白 鸟嘌呤核苷酸交换因子,解旋酶蛋白,免疫球蛋白超家族蛋白,抑制蛋白,蛋白激酶,脂质激酶,连接酶,脂质结合蛋白,甲基转移酶,运动蛋白,肌动蛋白, 氧化还原酶,磷酸二酯酶,磷脂酶,蛋白酶,受体蛋白,trascription因子,转移酶,翻译/转运蛋白和泛素缀合系统蛋白。